Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Perkins

Showing results (111-120 of 247) with videos related to

Pageof 25
Sort By:
Diabetes Care|April 24, 2025
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyBarbara H Braffett, Ionut Bebu, Gayle M Lorenzi, et al.
Clinical Endocrinology|December 31, 2013
White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals--the PROMISE cohortChee-Tin Christine Lee, Stewart B Harris, Ravi Retnakaran, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2007
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetesBruce A Perkins, Linda H Ficociello, Betsy E Ostrander, et al.
Plos One|September 13, 2014
Measurement of cooling detection thresholds for identification of diabetic sensorimotor polyneuropathy in type 1 diabetesZoe Lysy, Leif E Lovblom, Elise M Halpern, et al.
Plos One|May 5, 2012
Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetesBruce A Perkins, Naila Rabbani, Andrew Weston, et al.
Diabetes Care|March 1, 2012
Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetesJane E Yardley, Glen P Kenny, Bruce A Perkins, et al.
Journal of the Neurological Sciences|December 27, 2016
Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classesMajed Alabdali, Alon Abraham, Abdulla Alsulaiman, et al.
Diabetes Care|February 11, 2015
Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE CohortC Christine Lee, Bruce A Perkins, Sheena Kayaniyil, et al.
Journal of the Peripheral Nervous System : JPNS|May 18, 2026
Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab DebateGordon Sloan, Shazli Azmi, Stephanie Eid, et al.
Circulation|July 21, 2022
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme InhibitionYuliya Lytvyn, Karen Kimura, Nuala Peter, et al.
Pageof 25

Showing results (111-120 of 247) with videos related to

Sort By:
Pageof 25
Diabetes Care|April 24, 2025
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyBarbara H Braffett, Ionut Bebu, Gayle M Lorenzi, et al.
Clinical Endocrinology|December 31, 2013
White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals--the PROMISE cohortChee-Tin Christine Lee, Stewart B Harris, Ravi Retnakaran, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2007
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetesBruce A Perkins, Linda H Ficociello, Betsy E Ostrander, et al.
Plos One|September 13, 2014
Measurement of cooling detection thresholds for identification of diabetic sensorimotor polyneuropathy in type 1 diabetesZoe Lysy, Leif E Lovblom, Elise M Halpern, et al.
Plos One|May 5, 2012
Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetesBruce A Perkins, Naila Rabbani, Andrew Weston, et al.
Diabetes Care|March 1, 2012
Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetesJane E Yardley, Glen P Kenny, Bruce A Perkins, et al.
Journal of the Neurological Sciences|December 27, 2016
Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classesMajed Alabdali, Alon Abraham, Abdulla Alsulaiman, et al.
Diabetes Care|February 11, 2015
Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE CohortC Christine Lee, Bruce A Perkins, Sheena Kayaniyil, et al.
Journal of the Peripheral Nervous System : JPNS|May 18, 2026
Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab DebateGordon Sloan, Shazli Azmi, Stephanie Eid, et al.
Circulation|July 21, 2022
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme InhibitionYuliya Lytvyn, Karen Kimura, Nuala Peter, et al.
Pageof 25